GC Medical Science Corporation (KOSDAQ:142280)
South Korea · Delayed Price · Currency is KRW 3,425.00
-35.00 (-1.01%)
At close: Jun 10, 2026
GC Medical Science Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 4,473 | 3,666 | 3,581 | 1,797 | -3,581 | -21,202 |
Depreciation & Amortization | 3,968 | 3,930 | 3,786 | 3,854 | 4,107 | 3,831 |
Loss (Gain) From Sale of Assets | -15.45 | 0.34 | 210.98 | 9.99 | -3.55 | -3.77 |
Loss (Gain) From Sale of Investments | -263.56 | -263.56 | 428.89 | 396.55 | -650.69 | -49.98 |
Provision & Write-off of Bad Debts | -20.2 | -89 | -280.78 | 265.8 | 608.87 | 7,210 |
Other Operating Activities | -1,744 | -812.24 | -2,781 | 559.11 | -263.1 | 7,252 |
Change in Accounts Receivable | 1,132 | -3,491 | 3,896 | -1,432 | 502.23 | 908.72 |
Change in Inventory | 934.31 | 260.69 | -2,384 | 626.73 | 15,324 | -9,254 |
Change in Accounts Payable | -4,022 | 2,760 | -1,875 | 1,058 | -2,273 | -7,545 |
Change in Other Net Operating Assets | 2,572 | 1,233 | -921.56 | -2,894 | -2,891 | 658.53 |
Operating Cash Flow | 7,015 | 7,196 | 3,661 | 4,241 | 10,880 | -18,195 |
Operating Cash Flow Growth | 678.37% | 96.56% | -13.69% | -61.02% | - | - |
Capital Expenditures | -3,768 | -4,720 | -3,216 | -5,632 | -3,426 | -3,598 |
Sale of Property, Plant & Equipment | 753.05 | 941.18 | 24.79 | 8.81 | 300.15 | 124.39 |
Sale (Purchase) of Intangibles | -249.81 | -179.29 | -61.18 | -250 | -75.95 | - |
Investment in Securities | - | - | - | 1,793 | -2,472 | 740.98 |
Other Investing Activities | -72.75 | -71.84 | -5.15 | 256.95 | -0 | - |
Investing Cash Flow | -3,337 | -4,030 | -3,257 | -3,823 | -5,675 | -3,279 |
Short-Term Debt Issued | - | 32,500 | 12,000 | 13,800 | 29,940 | 129,900 |
Long-Term Debt Issued | - | - | 20,000 | - | 30,000 | - |
Total Debt Issued | 41,100 | 32,500 | 32,000 | 13,800 | 59,940 | 129,900 |
Short-Term Debt Repaid | - | -32,500 | -12,000 | -16,216 | -57,212 | -110,187 |
Long-Term Debt Repaid | - | -3,471 | -25,459 | -1,019 | -962.68 | -889.9 |
Total Debt Repaid | -45,577 | -35,971 | -37,459 | -17,235 | -58,175 | -111,077 |
Net Debt Issued (Repaid) | -4,477 | -3,471 | -5,459 | -3,435 | 1,765 | 18,823 |
Other Financing Activities | - | - | -4.96 | - | -0 | -0 |
Financing Cash Flow | -4,477 | -3,471 | -5,464 | -3,435 | 1,765 | 18,823 |
Foreign Exchange Rate Adjustments | 8.36 | - | -4.98 | 9.59 | -62.79 | 0.71 |
Miscellaneous Cash Flow Adjustments | -0 | - | - | - | - | - |
Net Cash Flow | -790.57 | -305.85 | -5,066 | -3,007 | 6,908 | -2,650 |
Free Cash Flow | 3,247 | 2,476 | 445.24 | -1,391 | 7,454 | -21,793 |
Free Cash Flow Growth | - | 456.00% | - | - | - | - |
Free Cash Flow Margin | 3.08% | 2.28% | 0.43% | -1.48% | 6.59% | -21.43% |
Free Cash Flow Per Share | 85.18 | 92.80 | 5.10 | -51.96 | 353.61 | -1034.47 |
Cash Interest Paid | 746.35 | 659.62 | 465.26 | 338.74 | 667.84 | 1,134 |
Cash Income Tax Paid | 7.26 | 8.11 | 21.62 | 134.94 | 65.83 | 232.3 |
Levered Free Cash Flow | -4,081 | -4,440 | -4,684 | -8,253 | 26,702 | -16,568 |
Unlevered Free Cash Flow | -2,362 | -2,727 | -2,919 | -6,185 | 28,499 | -15,835 |
Change in Working Capital | 616.78 | 763.57 | -1,285 | -2,641 | 10,662 | -15,232 |